145 related articles for article (PubMed ID: 34438209)
41. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
[TBL] [Abstract][Full Text] [Related]
42. Mesoporous silica nanoparticles for tissue-engineering applications.
Chen L; Zhou X; He C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1573. PubMed ID: 31294533
[TBL] [Abstract][Full Text] [Related]
43. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside.
Peng H; Dong R; Wang S; Zhang Z; Luo M; Bai C; Zhao Q; Li J; Chen L; Xiong H
Int J Pharm; 2013 Mar; 446(1-2):153-9. PubMed ID: 23395877
[TBL] [Abstract][Full Text] [Related]
44. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
45. Metabolite biomarkers of chlorothalonil exposure in earthworms, coelomic fluid, and coelomocytes.
Griffith CM; Thai AC; Larive CK
Sci Total Environ; 2019 Sep; 681():435-443. PubMed ID: 31112921
[TBL] [Abstract][Full Text] [Related]
46. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
47. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
48. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
49. Hepatic gene expression profiling in zebrafish (Danio rerio) exposed to the fungicide chlorothalonil.
Sánchez Garayzar AB; Bahamonde PA; Martyniuk CJ; Betancourt M; Munkittrick KR
Comp Biochem Physiol Part D Genomics Proteomics; 2016 Sep; 19():102-111. PubMed ID: 27264782
[TBL] [Abstract][Full Text] [Related]
50. Concept Design, Development and Preliminary Physical and Chemical Characterization of Tamoxifen-Guided-Mesoporous Silica Nanoparticles.
Day CM; Sweetman MJ; Hickey SM; Song Y; Liu Y; Zhang N; Plush SE; Garg S
Molecules; 2021 Jan; 26(1):. PubMed ID: 33406699
[TBL] [Abstract][Full Text] [Related]
51. Dual stimuli-responsive fungicide carrier based on hollow mesoporous silica/hydroxypropyl cellulose hybrid nanoparticles.
Gao Y; Liu Y; Qin X; Guo Z; Li D; Li C; Wan H; Zhu F; Li J; Zhang Z; He S
J Hazard Mater; 2021 Jul; 414():125513. PubMed ID: 34030404
[TBL] [Abstract][Full Text] [Related]
52. Surface functionalized mesoporous silica nanoparticles with natural proteins for reduced immunotoxicity.
Luo Z; Hu Y; Xin R; Zhang B; Li J; Ding X; Hou Y; Yang L; Cai K
J Biomed Mater Res A; 2014 Nov; 102(11):3781-94. PubMed ID: 24288246
[TBL] [Abstract][Full Text] [Related]
53. Systemic stereoselectivity study of bromothalonil: stereoselective bioactivity, toxicity, and degradation in vegetables and soil.
Liang X; Xu J; Huang X; Zheng Z; Zhang C; Yang Y; Wang M; Zhang Y
Pest Manag Sci; 2020 May; 76(5):1823-1830. PubMed ID: 31828964
[TBL] [Abstract][Full Text] [Related]
54. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic.
Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A
Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198
[TBL] [Abstract][Full Text] [Related]
55. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
56. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
57. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
58. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
59. Biocompatibility assessment of functionalized magnetic mesoporous silica nanoparticles in human HepaRG cells.
Pisani C; Rascol E; Dorandeu C; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Prat O
Nanotoxicology; 2017 Sep; 11(7):871-890. PubMed ID: 28937306
[TBL] [Abstract][Full Text] [Related]
60. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
